This message was sent to ##Email##
To advertise in this publication please click here
|
|
|
.SOCIETY NEWS
Research Donations Doubled for Giving Tuesday
AST
Giving Tuesday is on Tuesday, December 1. Thanks to the generous offer from CareDx, all donations up to $50,000 that are designated to research will be 100% matched from November 24 – December 8, 2020. Please help us maximize this opportunity by donating today.
|
|
Support Your COPs in the 2020 Donation Derby
AST
Help your COPs in the 2020 giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives, projects, and events. All donations made by COP members until the end of the year will count toward this contest, so be sure to check it out today.
|
|
AST Board Nominations Due November 30
AST
The AST is now accepting nominations for its 2021 Board of Directors. If you are interested in joining the AST Board, or know someone who is, we encourage you to submit your nomination. Learn more about the election process here.
|
|
|
|
 |
|
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
|
|
AST Seeking Volunteers for Reverse Expo at CEoT 2021
AST
The AST is seeking volunteers for our first Reverse Expo which will take place virtually during the Cutting Edge of Transplantation Meeting, February 25-27, 2021.
The Reverse Expo is a reversal of the traditional exhibit show format where the AST Expert Teams made up of members of different specialties, host a virtual "exhibit booth" while the AST's partners "walk the floor." Learn more about this volunteer opportunity here.
|
|
|
|
 |
|
- RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
- Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
|
|
FAST Applications Open
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 19, 2021. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
|
|
Advertisement
| |
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn more
|
|
|
Introducing the Living Donor Circle of Excellence
AST
The AST is proud to introduce the Living Donor Circle of Excellence program! The vision for this program was inspired by the need to increase living organ donation by removing financial barriers donors sometimes encounter. Today, many employers do not offer any kind of compensation to an employee recovering from donating an organ. The Circle aims to change that. By recognizing companies who support living donation through providing salary support post-surgery, the AST envisions more people will consider this altruistic act.
|
|
COVID-19 and Transplantation: AJT Articles
AST
In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
|
|
AST Research Network
AST
The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research.
|
|
|
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
|
|
|
|
|
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
.UPCOMING EDUCATION EVENTS
|
|
.TRANSPLANT NEWS
The Impact of Multi-Organ Transplant Allocation Priority on Waitlisted Kidney Transplant Candidates
American Journal of Transplantation
Kidney‐alone transplant (KAT) candidates may be disadvantaged by the allocation priority given to multi‐organ transplant (MOT) candidates. This study identified potential KAT candidates not receiving a given kidney offer due to its allocation for MOT. Using the Organ Procurement and Transplant Network (OPTN) database, we identified deceased donors from 2002 to 2017 who had one kidney allocated for MOT and the other kidney allocated for KAT or simultaneous pancreas–kidney transplant (SPK) (n = 7,378).
|
|
The Impact of Frailty on Mortality After Heart Transplantation
The Journal of Heart and Lung Transplantation
Frailty is prevalent in patients with advanced heart failure however its impact on clinical outcomes after heart transplantation is unclear. The aim of this study was to assess the impact of pre-transplant frailty on mortality and the duration of hospitalization after heart transplantation.
|
|
Liver Transplantation in a Patient With Human Immunodeficiency Virus and COVID-19
AASLD
The COVID‐19 pandemic has dramatically impacted the transplant community worldwide. Uncertainty and a lack of treatment protocols have resulted in a considerable reduction in, if not cessation of, transplantations. Wait‐list mortality remains high and problematic in this population. The optimal transplantation timing in infected candidates who have cleared the virus remains unclear.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
